The Royal Pharmaceutical Society of Great Britain has welcomed a move by the Medicines and Healthcare Products Regulatory Agency to reclassify azithromycin - an antibiotic used to treat chlamydia - as an over-the-counter drug.
It is the first time the agency has licensed an antibiotic for sale without a prescription. The Royal Pharmaceutical Society said the move would help improve access to chlamydia treatment.
For more details, go to www.mhra.gov.uk
A nationwide alert has been issued to hospitals after a series of incidents involving artificial breathing machines that have harmed patients.
An independent investigation into the attack and killing of two people on a hospital ward by another patient has concluded the attack was “probably preventable”, a leak of its report reveals.
NHS Improvement has announced that five of its directors are stepping down, as the organisation combines its management with NHS England.
We are aware that some of our users are experiencing problems accessing hsj.co.uk.
To protect your security as hsj.co.uk upgrades to a new platform, your existing password will no longer work.
Financial penalties are being lifted from high-profile standards including cancer and elective waiting times, so far without attracting much attention. How is this happening? And will it work, asks Rob Findlay
No comments yet